Drugs / Zi-Yin-Liang-Ge-San
Zi-Yin-Liang-Ge-San
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05040425 | Aug 2021 → Aug 2022 | head and neck cancer, mucositis | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zi-Yin-Liang-Ge-San | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05040425 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese herbal medicine treatment” NCT05040425 ↗ |
| Route | Oral | “It is orally administrated trice daily from the first day to the end of RT in the treatment group” NCT05040425 ↗ |